The one-time gene editing fix is meant to halt debilitating pain crises for sickle cell patients, who formerly could only be cured with a risky stem cell transplant.
The First Crispr Medicine Is Now Approved in the US
Brabus Launches ‘Deep Blue’ G-Wagon, Speedboat & Luxury Watch Line
Brabus is unifying its collaborations with Mercedes-AMG, Finland’s Axopar Boats, and Panerai luxury watches under one Deep Blue collection.Being that Brabus is...
